Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-12-03
1999-07-27
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540552, A01N 4346, C07D26702
Patent
active
059290684
ABSTRACT:
An optically active salt of 1,5-benzothiazepine compound of the formula (I) or (II): ##STR1## wherein each of Ring A and Ring B is a substituted or unsubstituted benzene ring, and R.sup.1 and R.sup.2 are the same or different and each is a lower alkyl group, can be prepared by resolving a racemic salt of 1,5-benzothiazepine compound of the formula (I) or (II) by means of preferential crystallization.
REFERENCES:
patent: 3562257 (1971-02-01), Kugita et al.
patent: 4567175 (1986-01-01), Takeda et al.
patent: 4931587 (1990-06-01), Piselli
patent: 5013834 (1991-05-01), Piselli
patent: 5128469 (1992-07-01), Nishimoto et al.
patent: 5134139 (1992-07-01), Kawai et al.
patent: 5183922 (1993-02-01), Rizzi et al.
H. Inoue, et al., "Synthesis of 1,5-Benzothiazepine Derivatives. IV. Resolution of )-1,5-benzothiazepin-4(5H)-one Hydrochloride," UDC, vol. 93, No. 6 (1973), pp. 729-732.
J. Jacques et al., Enantiomers, Racemates and Resolutions, John Wiley & Sons (New York), 1981, pp. 223-250.
H. Kugita et al., "Synthesis of 1,5-Benzothiazepine Derivatives. III," Chemical and Pharmaceutical Bulletin, vol. 19, No. 3 (1971), pp. 595-602.
Schwartz et. al., "Enantioselective Synthesis . . . Diltiazem Group", J. Org. Chem., vol. 57 (Jan. 31, 1992), No. 3, pp. 851-856.
Kojie-Prodie et. al., "Absolute Conformation and Configuration of . . . ", Helv. Chim. Acta, vol. 67 (1984), Fasc. 3, pp. 916-926.
Shibatani Takeji
Yamada Shin-ichi
Yoshioka Ryuzo
Ngo Tamthom T.
Raymond Richard L.
Tanabe Seiyaku Co. Ltd.
LandOfFree
Optically active benzothiazepine compounds and process for prepa does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Optically active benzothiazepine compounds and process for prepa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Optically active benzothiazepine compounds and process for prepa will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-878935